Skip to main content
Midas Edge

USBC, Inc.

For the period ended Mar 31, 2025. Filed May 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

USBC$0.37-3.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Changes in Stockholders’ Deficit

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY

Unaudited

Total
Series C ConvertiblePreferred Stock · Series D ConvertiblePreferred Stock · Common Stock · AdditionalPaid in · Accumulated · Stockholders'Equity/
Shares$Shares$Shares (1)$CapitalDeficit(Deficit)
Balance as of October 1, 202317,858$1,79010,161$1,0152,008,961$80,358$125,501,537$(121,840,788)$3,743,912.0
Stock compensation expense - employee options------699,246-699,246
Issuance of common stock for services----2,62510526,145-26,250
Deemed dividends on Series C and D Preferred Stock------63,629(63,629)-
Isssuance of common stock for common stock offering----22,077884202,221-203,105
Net loss-------(3,446,624)(3,446,624)
Balance as of December 31, 202317,8581,79010,1611,0152,033,66381,347126,492,778(125,351,041)1,225,889
Stock compensation expense - employee options------616,317-616,317
Issuance of common stock for services----8,712347170,413-170,760
Issuance of common stock for exercise of warrants----17,871715(715)--
Deemed dividends on Series C and D Preferred Stock------98,609(98,609)-
Expenses for extension of notes and warrants------594,761-594,761
Issuance of shares and warrants in connection with debt offering----2,5581031,035,860-1,035,963
Net loss-------(5,397,664)(5,397,664)
Balance as of March 31, 202417,8581,79010,1611,0152,062,80482,512129,008,023(130,847,314)(1,753,974)
Balance as of October 1, 202417,8581,79010,1611,0152,702,444108,021136,468,855(138,735,882)(2,156,201)
Stock compensation expense - employee options------550,703-550,703
Deemed dividends on Series C and D Preferred Stock------32,552(32,552)-
Isssuance of common stock for common stock offering----31,2501,250298,750-300,000
Issuance of common stock for debt payment----45,4551,818238,182-240,000
Repricing of convertible notes payable and warrants------1,302,607-1,302,607
Extension of warrants------513,499-513,499
Net loss-------(4,665,508)(4,665,508)
Balance as of December 31, 202417,8581,79010,1611,0152,779,149111,089139,405,148(143,433,942)(3,914,900)
Stock compensation expense - employee options------593,681-593,681
Deemed dividends on Series C and D Preferred Stock------23,662(23,662)-
Isssuance of common stock for At The Market common stock offering----379,4511,628509,077-510,705
Issuance of common stock for debt payment----383,118384505,617-506,001
Impact of reverse stock split due to rounding----(11)----
Net loss-------(3,579,036)(3,579,036)
Balance as of March 31, 202517,858$1,79010,161$1,0153,541,707$113,101$141,037,185$(147,036,640)$(5,883,549)
(1)Information pertaining to the number of shares outstanding gives retroactive effect to a 1 for 40 reverse stock split that became effective on February 19, 2025.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.